Back to trial details

Intake questionnaire

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

Applying to Rush University Medical Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 40 and 70 years old?
2. Have you been diagnosed with Relapsing Multiple Sclerosis?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chicago for study visits?